MedPath

Cholesterol Metabolism in Heterozygous Phytosterolemia

Phase 1
Completed
Conditions
Cardiovascular Disease
Interventions
Dietary Supplement: phytosterol ester
Registration Number
NCT01102647
Lead Sponsor
University of Manitoba
Brief Summary

The purpose of the study is to examine the effect of plant sterols on cholesterol absorption and synthesis in people with heterozygous phytosterolemia.

Detailed Description

A plant sterol supplementation study will be conducted in individuals who are heterozygous for phytosterolemia compared to non-carriers. The study will use a double-blind, randomised, crossover, placebo-controlled design in which participants will consume 2 treatments including 1.6 g of plant sterol pills and a placebo pill, each for 4 weeks. A 4 week washout period will separate the two treatment periods. Plant sterol concentrations will be measured by gas liquid chromatography and absorption will be measured by the ratio of campesterol to lathosterol in plasma. Cholesterol absorption and synthesis will be measured by dual stable isotope technique, involving simultaneous administration of 13C-cholesterol and deuterium oxide, respectively.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • heterozygous for phytosterolemia, wild-type.
Exclusion Criteria
  • Pregnant,
  • Previous heart attack,
  • Kidney disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Phytosterol esterphytosterol esterPlant sterol compared with placebo
Primary Outcome Measures
NameTimeMethod
Decrease in plasma LDL-cholesterol29 days

Other studies have found 10% reduction in plasma LDL-cholesterol after 2.2-3.2 gram of plant sterol supplementation for 4 weeks in heterozygous phytosterolemia.

Secondary Outcome Measures
NameTimeMethod
Increase plasma plant sterols29 days

We will use a control group and compare the level of increase in plasma plant sterol levels in both group over the course of plant sterol consumption

Trial Locations

Locations (1)

University of Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath